Brain wave test may end guesswork in ADHD drug choice
NCT ID NCT07650643
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a simple, non-invasive brain test (EEG) can predict which of two common ADHD medications—methylphenidate or amphetamines—works best for a child. About 220 children aged 7-11 with ADHD will try both medicines in a random order over 7 weeks. The goal is to replace the current trial-and-error approach with a personalized treatment plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital at Two Brookline Place
Brookline, Massachusetts, 02445, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peeking inside the ADHD brain: can two drugs rewire attention circuits?
- Can a common ADHD drug help kids with down syndrome?
- Could a gut makeover ease ADHD? a trial tests FMT in teens
- Can a virtual classroom train young brains to tune out distractions?
- A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
- Could a new drug help teens with ADHD?